List of Tables Table 01. Global Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 02. Global Pancreatic Enzyme Supplements, By Region, 2018-2026 ($Million) Table 03. List of Mucolytics Used To Treat Cystic Fibrosis Table 04. Global Mucolytics Cystic Fibrosis Therapeutics Market, By Region, 2018-2026 ($Million) Table 05. List of Bronchodilators Used To Treat Cystic Fibrosis Table 06. Global Bronchodilators Cystic Fibrosis Therapeutics Market, By Region, 2018-2026 ($Million) Table 07. List of Cftrs Used To Treat Cystic Fibrosis Table 08. Global Cftr Modulator Market, By Region, 2018-2026 ($Million) Table 09. Global Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 10. Global Cystic Fibrosis Therapeutics Market For Oral Route of Administration, By Region, 2018-2026 ($Million) Table 11. Global Cystic Fibrosis Therapeutics Market For Inhale Route of Administration, By Region, 2018-2026 ($Million) Table 12. Global Cystic Fibrosis Therapeutics Market, By Region, 2018-2026 ($Million) Table 13. North America Cystic Fibrosis Therapeutics Market, By Country, 2018-2026 ($Million) Table 14. U.S. Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 15. U.S. Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 16. Canada Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 17. Canada Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 18. Mexico Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 19. Mexico Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 20. North America Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 21. North America Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 22. Europe Cystic Fibrosis Therapeutics Market, By Country, 2018-2026 ($Million) Table 23. Germany Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 24. Germany Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 25. Uk Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 26. Uk Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 27. France Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 28. France Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 29. Rest of Europe Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 30. Rest of Europe Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 31. Europe Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 32. Asia-Pacific Cystic Fibrosis Therapeutics Market, By Country, 2018-2026 ($Million) Table 33. Japan Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 34. Japan Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 35. China Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 36. China Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 37. India Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 38. India Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 39. Australia Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 40. Australia Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 41. Rest of Asia-Pacific Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 42. Rest of Asia-Pacific Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 43. Asia-Pacific Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 44. Asia-Pacific Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 45. Lamea Cystic Fibrosis Therapeutics Market, By Country, 2018-2026 ($Million) Table 46. Brazil Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 47. Brazil Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 48. South Africa Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 49. South Africa Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 50. Saudi Arabia Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 51. Saudi Arabia Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 52. Rest of Lamea Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 53. Rest of Lamea Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 54. Lamea Cystic Fibrosis Therapeutics Market, By Drug Class, 2018-2026 ($Million) Table 55. Lamea Cystic Fibrosis Therapeutics Market, By Route of Administration, 2018-2026 ($Million) Table 56. Roche: Company Snapshot Table 57. Roche: Operating Segments Table 58. Roche Plc: Product Portfolio Table 59. Novartis Ag Inc.: Company Snapshot Table 60. Novartis Ag Inc.: Operating Segments Table 61. Novartis Ag Inc.: Product Portfolio Table 62. Gilead Sciences, Inc.: Company Snapshot Table 63. Gilead Sciences, Inc.: Operating Segments Table 64. Gilead Sciences, Inc.: Product Portfolio: Table 65. Vertex Pharmaceuticals Incorporated: Company Snapshot Table 66. Vertex Pharmaceuticals Incorporated: Operating Segments Table 67. Vertex Pharmaceuticals Incorporated: Product Portfolio Table 68. Abbvie Inc.: Company Snapshot Table 69. Abbvie Inc.: Operating Segments Table 70. Abbvie Inc.: Product Portfolio Table 71. Glaxosmithkline Plc.: Company Snapshot Table 72. Glaxosmithkline Plc.: Operating Segments Table 73. Glaxosmithkline Plc.: Product Portfolio Table 74. Teva Pharmaceutical Industries Ltd.: Company Snapshot Table 75. Teva Pharmaceutical Industries Pharmaceutical Industries Ltd.: Operating Segments Table 76. Teva Pharmaceutical Industries Ltd.: Product Portfolio Table 77. Allergan Plc: Company Snapshot Table 78. Allergan Plc: Operating Segments Table 79. Allergan Plc: Product Portfolio Table 80. Pharmaxis Ltd: Company Snapshot Table 81. Pharmaxis Ltd: Product Segments Table 82. Pharmaxis Ltd: Product Portfolio Table 83. Mylan N.V.: Company Snapshot Table 84. Mylan N.V.: Operating Segments Table 85. Mylan N.V: Product Portfolio
List of Figures Figure 01. Cystic Fibrosis Therapeutics Market Segmentation Figure 02. Low Bargaining Power of Suppliers Figure 03. High Bargaining Power of Buyers Figure 04. High Threat of Substitution Figure 05. High Threat of New Entrants Figure 06. High Competitive Rivalry Figure 07. Top Player Positioning Figure 08. Global Cystic Fibrosis Therapeutics Market: Drivers, Restraints, And Opportunities Figure 09. Comparative Share Analysis of Pancreatic Enzyme Supplements Market, By Country, 2018 & 2026 (%) Figure 10. Comparative Share Analysis of Mucolytics Cystic Fibrosis Therapeutics Market, By Country, 2018 & 2026 (%) Figure 11. Comparative Share Analysis of Bronchodilators Cystic Fibrosis Therapeutics Market, By Country, 2018 & 2026 (%) Figure 12. Comparative Share Analysis of Cftr Modulator Market, By Country, 2018 & 2026 (%) Figure 13. Comparative Share Analysis of Cystic Fibrosis Therapeutics Market For Oral Route of Administration By Country, 2018 & 2026 (%) Figure 14. Comparative Share Analysis of Cystic Fibrosis Therapeutics Market For Inhale Route of Administration By Country, 2018 & 2026 (%) Figure 15. Roche: Revenue Share By Geography, 2018 (%) Figure 16. Roche: Revenue Share By Segment, 2018 (%) Figure 17. Roche: Revenue Share By Geography, 2018 (%) Figure 18. Novartis Ag Inc: Net Sales, 2016-2018 ($Million) Figure 19. Novartis Ag Inc: Revenue Share By Segment, 2018 (%) Figure 20. Novartis Ag Inc.: Revenue Share By Region, 2018(%) Figure 21. Gilead Sciences Inc.: Net Sales, 2016-2018 ($Million) Figure 22. Gilead Sciences Inc.: Revenue Share By Region, 2018(%) Figure 23. Gilead Sciences Inc.: Revenue Share By Segment, 2018 (%) Figure 24. Vertex Pharmaceutical Inc.: Net Sales, 2016-2018 ($Million) Figure 25. Vertex Pharmaceutical Inc.: Revenue Share By Segment, 2018 (%) Figure 26. Abbvie Inc.: Net Sales, 2016-2018 ($Million) Figure 27. Abbvie Inc.: Revenue Share By Regions, 2018 (%) Figure 28. Abbvie Inc.: Revenue Share By Segment, 2018 (%) Figure 29. Glaxosmithkline Plc.: Net Sales, 2016-2018 ($Million) Figure 30. Glaxosmithkline Plc.: Revenue Share By Region, 2018(%) Figure 31. Glaxosmithkline Plc.: Revenue Share By Segment, 2018 (%) Figure 32. Teva Pharmaceutical Industries: Net Sales, 2016-2018 ($Million) Figure 33. Teva Pharmaceutical Industries: Revenue Share By Segments 2018 ($Million) Figure 34. Allergan Plc: Net Sales, 2016-2018 ($Million) Figure 35. Allergan Plc: Revenue Share By Segment, 2018 (%) Figure 36. Mylan N.V.: Net Sales, 2016-2018 ($Million) Figure 37. Mylan N.V.: Revenue Share By Region, 2018(%)
